Biodesix (BDSX) Asset Writedowns and Impairment (2019 - 2026)
Biodesix's (BDSX) quarterly Asset Writedowns and Impairment came in at $20000.0 in Q1 2026, down 72.6% YoY from $73000.0 in Q1 2025, and up 135.09% on a QoQ basis from -$57000.0 in Q4 2025.
Biodesix (BDSX) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends
Biodesix (BDSX) has 8 years of Asset Writedowns and Impairment data on file, last reported at $20000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 72.6% year-over-year to $20000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4000.0 (down 101.65% YoY) and the FY2025 annual result came in at $49000.0, down 79.41% from the prior year.
- Asset Writedowns and Impairment advanced to $20000.0 in Q1 2026, from -$57000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $454000.0 in Q2 2022 to a low of -$562000.0 in Q3 2022.
- A 5-year average of $33000.0 and a median of $46500.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment plunged 221.05% — and 2025, when it jumped 812.5%.
- Tracing BDSX's Asset Writedowns and Impairment over 5 years: stood at $108000.0 in 2022, then retreated by 21.3% to $85000.0 in 2023, then jumped by 156.47% to $218000.0 in 2024, then tumbled by 126.15% to -$57000.0 in 2025, then surged by 135.09% to $20000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $20000.0 (Q1 2026), -$57000.0 (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Biodesix | 292.51 Mn | 262.51 Mn | 22.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,000.00 |
| Jun 30, 2026 | 12,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | -267,000.00 |
| Dec 31, 2023 | -267,000.00 |